Zonegran

Zonegran is a drug that is approved for use with other seizure medications to control partial seizures. It works by stopping seizure activity from starting and preventing it from spreading to other parts of the brain. The drug comes in capsule form and is generally taken once or twice a day. Common side effects of Zonegran include drowsiness, nausea, and headaches.

What Is Zonegran?

Zonegran® (zonisamide) is a prescription medication used to treat partial seizures, a specific type of epileptic seizure. Seizures are divided into two major categories: partial seizures (sometimes called focal seizures) and generalized seizures. Partial seizures occur in just one part of the brain, while generalized seizures affect both sides of the brain. Zonegran is approved to be used together with other seizure medications to control partial seizures.
 
(Click Zonegran Uses for more information, including possible off-label uses.)
 

Who Makes It?

Currently, Zonegran is made by Eisai, Inc.
 

How Does Zonegran Work?

Epilepsy is a brain disorder caused by recurring, brief changes in the brain's electrical system. These changes in brain activity can lead to a seizure (see Epilepsy Symptoms).
 
It is not known exactly how Zonegran works to prevent partial seizures in people with epilepsy. It may work by blocking sodium channels in the brain, which could decrease activity of nerve cells, preventing them from firing abnormally. The medication may also affect calcium in the brain. Evidence suggests that the medication works to stop seizure activity from starting and preventing it from spreading to other parts of the brain.
 
Know the Signs - Concussion Safety

Zonegran Drug Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2014 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.